Johnson & Johnson’s Covid-19 Live Web Series Has Found a Global Audience

The first season of The Road to a Vaccine had 90 million views in 100 countries

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Johnson & Johnson, the New Jersey-based health-care manufacturer behind Tylenol, Motrin and Zyrtec, has a new hit on its hands that’s not available for sale over the counter.

In April, J&J debuted The Road to a Vaccine, a live web series hosted by journalist Lisa Ling that documents the company’s search for a coronavirus vaccine and features interviews with health experts and J&J scientists. So far, Season 1’s eight episodes, which originally aired between mid-April to early June, have attracted 90 million views from more than 100 countries, according to the company.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in